Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for WBC's Women's Capital Summit
May 21-22, 2025 • New York
The WBC Women’s Capital Summit aims to provide valuable insights into the world of capital, offering a deep understanding of its dynamics, strategic relevance at different stages of a company’s growth, and the effective utilization of capital resources.
Sara Armbruster is the President and CEO of Steelcase Inc assuming the role in October 2021. In past roles, Sara has had responsibility for a range of innovation activities including
Sara Armbruster is the President and CEO of Steelcase Inc assuming the role in October 2021. In past roles, Sara has had responsibility for a range of innovation activities including
Sarah Boyce brings to Avidity extensive experience in the life sciences industry, where she has built global organizations and brought to patients a number of innovative therapies, including Tegsedi®, Waylivra®,
Sarah Boyce brings to Avidity extensive experience in the life sciences industry, where she has built global organizations and brought to patients a number of innovative therapies, including Tegsedi®, Waylivra®,
Priscilla Sims Brown is the CEO of Amalgamated Financial Corp., a leading provider of financial services with a strong focus on social responsibility and impact investing. Browns leadership is defined
Priscilla Sims Brown is the CEO of Amalgamated Financial Corp., a leading provider of financial services with a strong focus on social responsibility and impact investing. Browns leadership is defined
Rachel E. Haurwitz, Ph.D., is the CEO of Caribou Biosciences, Inc., a biotechnology company specializing in CRISPR-based gene editing technologies. Dr. Haurwitzs leadership is characterized by her commitment to advancing
Rachel E. Haurwitz, Ph.D., is the CEO of Caribou Biosciences, Inc., a biotechnology company specializing in CRISPR-based gene editing technologies. Dr. Haurwitzs leadership is characterized by her commitment to advancing
Rachel McMinn, Ph.D., is the CEO of Neurogene Inc., a biopharmaceutical company focused on developing innovative gene therapies for neurological disorders. Dr. McMinns leadership is marked by her dedication to
Rachel McMinn, Ph.D., is the CEO of Neurogene Inc., a biopharmaceutical company focused on developing innovative gene therapies for neurological disorders. Dr. McMinns leadership is marked by her dedication to
Reshma is the Chief Executive Officer and President at Vertex, a Fortune 500, global biotechnology company. She trained in internal medicine and nephrology before entering the biopharmaceutical industry, where she
Reshma is the Chief Executive Officer and President at Vertex, a Fortune 500, global biotechnology company. She trained in internal medicine and nephrology before entering the biopharmaceutical industry, where she
Phebe N. Novakovic has been the Chairman and Chief Executive Officer of General Dynamics since 2013. She was the President and Chief Operating Officer of General Dynamics in 2012, Executive
Phebe N. Novakovic has been the Chairman and Chief Executive Officer of General Dynamics since 2013. She was the President and Chief Operating Officer of General Dynamics in 2012, Executive
Patricia K. Collawn is the CEO of PNM Resources, Inc., an energy holding company providing electricity and energy services. Collawns leadership is marked by a commitment to operational excellence, sustainability,
Patricia K. Collawn is the CEO of PNM Resources, Inc., an energy holding company providing electricity and energy services. Collawns leadership is marked by a commitment to operational excellence, sustainability,
Patricia K. Poppe is the Chief Executive Officer of San Francisco-based PG&E Corporation. Poppe joined PG&E in January 2021 after five years as President and CEO of CMS Energy and
Patricia K. Poppe is the Chief Executive Officer of San Francisco-based PG&E Corporation. Poppe joined PG&E in January 2021 after five years as President and CEO of CMS Energy and
Paula Ragan, Ph.D., is the CEO of X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapies for rare and serious diseases. Dr. Ragans leadership is characterized by a
Paula Ragan, Ph.D., is the CEO of X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapies for rare and serious diseases. Dr. Ragans leadership is characterized by a
